cancer-biology

No description yet: the sentence for this tag has not been written. 8 records carry it: 8 people. Also written “cancer biology”; the spellings share this page.

Related tags

8 recordsDownload

	Cancers		Other tags
Aaron Ciechanover Distinguished Research Professor, Rappaport-Technion Integrated Cancer Center and Rappaport Faculty of Medicine, Technion · Technion, Israel Institute of Technology Shared the 2004 Nobel Prize in Chemistry for discovering how cells label proteins for destruction. That labelling system is what proteasome inhibitors block and what every protein degrader hijacks.	Multiple myeloma	none	scientist, nobel-laureate
Avram Hershko Distinguished Professor, Department of Biochemistry, Rappaport Faculty of Medicine, Technion · Technion, Israel Institute of Technology Shared the 2004 Nobel Prize in Chemistry for the discovery of ubiquitin-mediated protein degradation, and still works on how the machinery that destroys proteins controls cell division.	none	none	scientist, nobel-laureate
Florian R. Greten Director, Georg-Speyer-Haus (Institute for Tumor Biology and Experimental Therapy) · University Cancer Center Frankfurt (UCT) Tumour biologist known for linking inflammation to cancer, directing the Georg-Speyer-Haus within UCT Frankfurt.	Colorectal cancer, Gastric & gastro-oesophageal junction cancer	none	leadership, clinician-scientist, colorectal cancer
Lars Zender Deputy Speaker; Medical Director, Internal Medicine VIII (Medical Oncology and Pulmonology) · Comprehensive Cancer Center Tübingen-Stuttgart Medical oncologist and cancer biologist at Tübingen, known for work on senescence surveillance and functional genomics in liver cancer.	Hepatocellular carcinoma	none	leadership, clinician-scientist, liver cancer
Moshe Oren Professor, Department of Molecular Cell Biology, Weizmann Institute of Science · Weizmann Institute of Science Cloned p53 and then spent a career on what it does. The field's first reading of his own 1984 result, that p53 was an oncogene, turned out to be wrong, and the correction is the better story.	none	none	scientist
Patrick Mehlen Director of Fundamental and Translational Research and of the Cancer Research Center of Lyon (CRCL) · Centre Léon Bérard Cancer biologist who discovered the dependence-receptor concept and took netrin-1 blockade from bench to clinical trials at Centre Léon Bérard.	Endometrial cancer	none	leadership, clinician-scientist, drug development
Senthil K. Muthuswamy Director, Center for Cancer Research, National Cancer Institute · NCI Center for Cancer Research (intramural programme) Cancer biologist who directs the National Cancer Institute's Center for Cancer Research, the large intramural research programme in Bethesda.	Pancreatic ductal adenocarcinoma, HR-positive / HER2-negative breast cancer	none	leadership, clinician-scientist, organoids
Yosef Yarden Professor, Department of Immunology and Regenerative Biology, Weizmann Institute of Science · Weizmann Institute of Science One of the people who worked out what the HER family of receptors does and how antibodies against them behave, including why combining two antibodies against the same receptor works better than either alone.	HER2-positive breast cancer, Non-small-cell lung cancer	none	scientist

This tag as JSON · API

Aaron Ciechanover

Distinguished Research Professor, Rappaport-Technion Integrated Cancer Center and Rappaport Faculty of Medicine, Technion · Technion, Israel Institute of Technology

Shared the 2004 Nobel Prize in Chemistry for discovering how cells label proteins for destruction. That labelling system is what proteasome inhibitors block and what every protein degrader hijacks.

Avram Hershko

Distinguished Professor, Department of Biochemistry, Rappaport Faculty of Medicine, Technion · Technion, Israel Institute of Technology

Shared the 2004 Nobel Prize in Chemistry for the discovery of ubiquitin-mediated protein degradation, and still works on how the machinery that destroys proteins controls cell division.

Florian R. Greten

Director, Georg-Speyer-Haus (Institute for Tumor Biology and Experimental Therapy) · University Cancer Center Frankfurt (UCT)

Tumour biologist known for linking inflammation to cancer, directing the Georg-Speyer-Haus within UCT Frankfurt.

Lars Zender

Deputy Speaker; Medical Director, Internal Medicine VIII (Medical Oncology and Pulmonology) · Comprehensive Cancer Center Tübingen-Stuttgart

Medical oncologist and cancer biologist at Tübingen, known for work on senescence surveillance and functional genomics in liver cancer.

Moshe Oren

Professor, Department of Molecular Cell Biology, Weizmann Institute of Science · Weizmann Institute of Science

Cloned p53 and then spent a career on what it does. The field's first reading of his own 1984 result, that p53 was an oncogene, turned out to be wrong, and the correction is the better story.

Patrick Mehlen

Director of Fundamental and Translational Research and of the Cancer Research Center of Lyon (CRCL) · Centre Léon Bérard

Cancer biologist who discovered the dependence-receptor concept and took netrin-1 blockade from bench to clinical trials at Centre Léon Bérard.

Senthil K. Muthuswamy

Director, Center for Cancer Research, National Cancer Institute · NCI Center for Cancer Research (intramural programme)

Cancer biologist who directs the National Cancer Institute's Center for Cancer Research, the large intramural research programme in Bethesda.

Yosef Yarden

Professor, Department of Immunology and Regenerative Biology, Weizmann Institute of Science · Weizmann Institute of Science

One of the people who worked out what the HER family of receptors does and how antibodies against them behave, including why combining two antibodies against the same receptor works better than either alone.